{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:08:16Z","timestamp":1761894496204},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2007,3,22]],"date-time":"2007-03-22T00:00:00Z","timestamp":1174521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,3,22]],"date-time":"2007-03-22T00:00:00Z","timestamp":1174521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1038\/sj.leu.2404653","type":"journal-article","created":{"date-parts":[[2007,3,22]],"date-time":"2007-03-22T08:03:17Z","timestamp":1174550597000},"page":"1224-1231","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["DNA profiling analysis of 100 consecutive de novo acute myeloid leukemia cases reveals patterns of genomic instability that affect all cytogenetic risk groups"],"prefix":"10.1038","volume":"21","author":[{"given":"J","family":"Suela","sequence":"first","affiliation":[]},{"given":"S","family":"\u00c1lvarez","sequence":"additional","affiliation":[]},{"given":"F","family":"Cifuentes","sequence":"additional","affiliation":[]},{"given":"C","family":"Largo","sequence":"additional","affiliation":[]},{"given":"B I","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"D","family":"Blesa","sequence":"additional","affiliation":[]},{"given":"M","family":"Ardanaz","sequence":"additional","affiliation":[]},{"given":"R","family":"Garc\u00eda","sequence":"additional","affiliation":[]},{"given":"J A","family":"Marquez","sequence":"additional","affiliation":[]},{"given":"M D","family":"Odero","sequence":"additional","affiliation":[]},{"given":"M J","family":"Calasanz","sequence":"additional","affiliation":[]},{"given":"J C","family":"Cigudosa","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2007,3,22]]},"reference":[{"key":"BF2404653_CR1","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1056\/NEJM199909303411407","volume":"341","author":"B Lowenberg","year":"1999","unstructured":"Lowenberg B, Downing JR, Burnett A . Acute myeloid leukemia. N Engl J Med 1999; 341: 1051\u20131062.","journal-title":"N Engl J Med"},{"key":"BF2404653_CR2","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00277-005-1099-0","volume":"84","author":"U Bacher","year":"2005","unstructured":"Bacher U, Kern W, Schnittger S, Hiddemann W, Schoch C, Haferlach T . Further correlations of morphology according to FAB and WHO classification to cytogenetics in de novo acute myeloid leukemia: a study on 2,235 patients. Ann Hematol 2005; 84: 785\u2013791.","journal-title":"Ann Hematol"},{"key":"BF2404653_CR3","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1182\/blood.V92.7.2322","volume":"92","author":"D Grimwade","year":"1998","unstructured":"Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998; 92: 2322\u20132333.","journal-title":"Blood"},{"key":"BF2404653_CR4","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1182\/blood-2002-03-0772","volume":"100","author":"JC Byrd","year":"2002","unstructured":"Byrd JC, Mrozek K, Dodge RK, Carroll AJ, Edwards CG, Arthur DC et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood 2002; 100: 4325\u20134336.","journal-title":"Blood"},{"key":"BF2404653_CR5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0268-960X(03)00040-7","volume":"18","author":"K Mrozek","year":"2004","unstructured":"Mrozek K, Heerema NA, Bloomfield CD . Cytogenetics in acute leukemia. Blood Rev 2004; 18: 115\u2013136.","journal-title":"Blood Rev"},{"key":"BF2404653_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.critrevonc.2003.11.002","volume":"50","author":"M Smith","year":"2004","unstructured":"Smith M, Barnett M, Bassan R, Gatta G, Tondini C, Kern W . Adult acute myeloid leukaemia. Crit Rev Oncol Hematol 2004; 50: 197\u2013222.","journal-title":"Crit Rev Oncol Hematol"},{"key":"BF2404653_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1182\/blood.V100.1.29","volume":"100","author":"SR Wolman","year":"2002","unstructured":"Wolman SR, Gundacker H, Appelbaum FR, Slovak ML . Impact of trisomy 8 (+8) on clinical presentation, treatment response, and survival in acute myeloid leukemia: a Southwest Oncology Group study. Blood 2002; 100: 29\u201335.","journal-title":"Blood"},{"key":"BF2404653_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1146\/annurev.genom.3.032802.115046","volume":"3","author":"L Kelly","year":"2002","unstructured":"Kelly L . Genetics of Myeloid Leukemias. Annu Rev Genomics Hum Genet 2002; 3: 179\u2013198.","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"BF2404653_CR9","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.1182\/blood-2005-08-3453","volume":"107","author":"DL Stirewalt","year":"2006","unstructured":"Stirewalt DL, Kopecky KJ, Meshinchi S, Engel JH, Pogosova-Agadjanyan EL, Linsley J et al. Size of FLT3 internal tandem duplication has prognostic significance in patients with acute myeloid leukemia. Blood 2006; 107: 3724\u20133726.","journal-title":"Blood"},{"key":"BF2404653_CR10","doi-asserted-by":"publisher","first-page":"4372","DOI":"10.1182\/blood-2002-05-1440","volume":"100","author":"S Frohling","year":"2002","unstructured":"Frohling S, Schlenk RF, Breitruck J, Benner A, Kreitmeier S, Tobis K et al. Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm. Blood 2002; 100: 4372\u20134380.","journal-title":"Blood"},{"key":"BF2404653_CR11","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1182\/blood-2005-06-2248","volume":"106","author":"S Schnittger","year":"2005","unstructured":"Schnittger S, Schoch C, Kern W, Mecucci C, Tschulik C, Martelli MF et al. Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype. Blood 2005; 106: 3733\u20133739.","journal-title":"Blood"},{"key":"BF2404653_CR12","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1182\/blood-2005-04-1733","volume":"106","author":"T Suzuki","year":"2005","unstructured":"Suzuki T, Kiyoi H, Ozeki K, Tomita A, Yamaji S, Suzuki R et al. Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia. Blood 2005; 106: 2854\u20132861.","journal-title":"Blood"},{"key":"BF2404653_CR13","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1182\/blood-2004-12-4938","volume":"106","author":"T Haferlach","year":"2005","unstructured":"Haferlach T, Kohlmann A, Schnittger S, Dugas M, Hiddemann W, Kern W et al. Global approach to the diagnosis of leukemia using gene expression profiling. Blood 2005; 106: 1189\u20131198.","journal-title":"Blood"},{"key":"BF2404653_CR14","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1073\/pnas.98.3.1124","volume":"98","author":"K Virtaneva","year":"2001","unstructured":"Virtaneva K, Wright FA, Tanner SM, Yuan B, Lemon WJ, Caligiuri MA et al. Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics. Proc Natl Acad Sci USA 2001; 98: 1124\u20131129.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2404653_CR15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1158\/0008-5472.375.65.2","volume":"65","author":"M Raghavan","year":"2005","unstructured":"Raghavan M, Lillington DM, Skoulakis S, Debernardi S, Chaplin T, Foot NJ et al. Genome-wide single nucleotide polymorphism analysis reveals frequent partial uniparental disomy due to somatic recombination in acute myeloid leukemias. Cancer Res 2005; 65: 375\u2013378.","journal-title":"Cancer Res"},{"key":"BF2404653_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0165-4608(02)00930-5","volume":"144","author":"A Martinez-Ramirez","year":"2003","unstructured":"Martinez-Ramirez A, Urioste M, Calasanz MJ, Cigudosa JC, Benitez J . Array comparative genomic hybridization analysis of myelodysplastic syndromes with complex karyotypes. A technical evaluation. Cancer Genet Cytogenet 2003; 144: 87\u201389.","journal-title":"Cancer Genet Cytogenet"},{"key":"BF2404653_CR17","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/gcc.20154","volume":"42","author":"A Martinez-Ramirez","year":"2005","unstructured":"Martinez-Ramirez A, Urioste M, Melchor L, Blesa D, Valle L, de Andres SA et al. Analysis of myelodysplastic syndromes with complex karyotypes by high-resolution comparative genomic hybridization and subtelomeric CGH array. Genes Chromosomes Cancer 2005; 42: 287\u2013298.","journal-title":"Genes Chromosomes Cancer"},{"key":"BF2404653_CR18","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/sj.leu.2404145","volume":"20","author":"K Paulsson","year":"2006","unstructured":"Paulsson K, Heidenblad M, Strombeck B, Staaf J, Jonsson G, Borg A et al. High-resolution genome-wide array-based comparative genome hybridization reveals cryptic chromosome changes in AML and MDS cases with trisomy 8 as the sole cytogenetic aberration. Leukemia 2006; 20: 840\u2013846.","journal-title":"Leukemia"},{"key":"BF2404653_CR19","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1200\/JCO.2005.04.5450","volume":"24","author":"FG Rucker","year":"2006","unstructured":"Rucker FG, Bullinger L, Schwaenen C, Lipka DB, Wessendorf S, Frohling S et al. Disclosure of Candidate Genes in Acute Myeloid Leukemia With Complex Karyotypes Using Microarray-Based Molecular Characterization. J Clin Oncol 2006; 24: 3887\u20133894.","journal-title":"J Clin Oncol"},{"key":"BF2404653_CR20","doi-asserted-by":"publisher","first-page":"17765","DOI":"10.1073\/pnas.0407979101","volume":"101","author":"MT Barrett","year":"2004","unstructured":"Barrett MT, Scheffer A, Ben-Dor A, Sampas N, Lipson D, Kincaid R et al. Comparative genomic hybridization using oligonucleotide microarrays and total genomic DNA. Proc Natl Acad Sci USA 2004; 101: 17765\u201317770.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2404653_CR21","first-page":"3074","volume":"93","author":"H Kiyoi","year":"1999","unstructured":"Kiyoi H, Naoe T, Nakano Y, Yokota S, Minami S, Miyawaki S et al. Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia. Blood 1999; 93: 3074\u20133080.","journal-title":"Blood"},{"key":"BF2404653_CR22","first-page":"54","volume":"90","author":"L Suarez","year":"2005","unstructured":"Suarez L, Vidriales MB, Moreno MJ, Lopez A, Garcia-Larana J, Perez-Lopez C et al. Differences in anti-apoptotic and multidrug resistance phenotypes in elderly and young acute myeloid leukemia patients are related to the maturation of blast cells. Haematologica 2005; 90: 54\u201359.","journal-title":"Haematologica"},{"issue":"Web Server issu","key":"BF2404653_CR23","doi-asserted-by":"publisher","first-page":"W616","DOI":"10.1093\/nar\/gki500","volume":"33","author":"JM Vaquerizas","year":"2005","unstructured":"Vaquerizas JM, Conde L, Yankilevich P, Cabezon A, Minguez P, Diaz-Uriarte R et al. GEPAS, an experiment-oriented pipeline for the analysis of microarray gene expression data. Nucleic Acids Res 2005; 33 (Web Server issue): W616\u2013W620.","journal-title":"Nucleic Acids Res"},{"key":"BF2404653_CR24","unstructured":"The Database of Genomic Variants 2005, Accession Date: 20th December 2006. http:\/\/projects.tcag.ca\/variation."},{"key":"BF2404653_CR25","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ccr.2006.03.019","volume":"9","author":"DR Carrasco","year":"2006","unstructured":"Carrasco DR, Tonon G, Huang Y, Zhang Y, Sinha R, Feng B et al. High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients. Cancer Cell 2006; 9: 313\u2013325.","journal-title":"Cancer Cell"},{"key":"BF2404653_CR26","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/gcc.10180","volume":"36","author":"JC Cigudosa","year":"2003","unstructured":"Cigudosa JC, Odero MD, Calasanz MJ, Sole F, Salido M, Arranz E et al. De novo erythroleukemia chromosome features include multiple rearrangements, with special involvement of chromosomes 11 and 19. Genes Chromosomes Cancer 2003; 36: 406\u2013412.","journal-title":"Genes Chromosomes Cancer"},{"key":"BF2404653_CR27","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/gcc.20289","volume":"45","author":"K Wimmer","year":"2006","unstructured":"Wimmer K, Yao S, Claes K, Kehrer-Sawatzki H, Tinschert S, De Raedt T et al. Spectrum of single- and multiexon NF1 copy number changes in a cohort of 1,100 unselected NF1 patients. Genes Chromosomes Cancer 2006; 45: 265\u2013276.","journal-title":"Genes Chromosomes Cancer"},{"key":"BF2404653_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1182\/blood-2005-11-4354","volume":"108","author":"SS Farag","year":"2006","unstructured":"Farag SS, Archer KJ, Mrozek K, Ruppert AS, Carroll AJ, Vardiman JW et al. Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from cancer and leukemia group B 8461. Blood 2006; 108: 63\u201373.","journal-title":"Blood"},{"key":"BF2404653_CR29","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1182\/blood-2004-12-4633","volume":"108","author":"CS Wilson","year":"2006","unstructured":"Wilson CS, Davidson GS, Martin SB, Andries E, Potter J, Harvey R et al. Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction. Blood 2006; 108: 685\u2013696.","journal-title":"Blood"},{"key":"BF2404653_CR30","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1056\/NEJMoa031046","volume":"350","author":"L Bullinger","year":"2004","unstructured":"Bullinger L, Dohner K, Bair E, Frohling S, Schlenk RF, Tibshirani R et al. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med 2004; 350: 1605\u20131616.","journal-title":"N Engl J Med"},{"key":"BF2404653_CR31","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/01.moh.0000148760.15412.df","volume":"12","author":"I Avivi","year":"2005","unstructured":"Avivi I, Rowe JM . Prognostic factors in acute myeloid leukemia. Curr Opin Hematol 2005; 12: 62\u201367.","journal-title":"Curr Opin Hematol"},{"issue":"Suppl 13","key":"BF2404653_CR32","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00277-005-0005-0","volume":"84","author":"O Galm","year":"2005","unstructured":"Galm O, Wilop S, Luders C, Jost E, Gehbauer G, Herman JG et al. Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia. Ann Hematol 2005; 84 (Suppl 13): 39\u201349.","journal-title":"Ann Hematol"},{"key":"BF2404653_CR33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/hon.744","volume":"23","author":"S Alvarez","year":"2005","unstructured":"Alvarez S, Cigudosa JC . Gains, losses and complex karyotypes in myeloid disorders: a light at the end of the tunnel. Hematol Oncol 2005; 23: 18\u201325.","journal-title":"Hematol Oncol"},{"key":"BF2404653_CR34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cancergencyto.2005.09.007","volume":"165","author":"D Trost","year":"2006","unstructured":"Trost D, Hildebrandt B, Beier M, Muller N, Germing U, Royer-Pokora B . Molecular cytogenetic profiling of complex karyotypes in primary myelodysplastic syndromes and acute myeloid leukemia. Cancer Genet Cytogenet 2006; 165: 51\u201363.","journal-title":"Cancer Genet Cytogenet"},{"key":"BF2404653_CR35","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/sj.leu.2404543","volume":"21","author":"A Tyybakinoja","year":"2007","unstructured":"Tyybakinoja A, Elonen E, Piippo K, Porkka K, Knuutila S . Oligonucleotide array-CGH reveals cryptic gene copy number alterations in karyotypically normal acute myeloid leukemia. Leukemia 2007; 21: 571\u2013574.","journal-title":"Leukemia"},{"key":"BF2404653_CR36","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/gcc.20234","volume":"44","author":"TA Gorletta","year":"2005","unstructured":"Gorletta TA, Gasparini P, D'Elios MM, Trubia M, Pelicci PG, Di Fiore PP . Frequent loss of heterozygosity without loss of genetic material in acute myeloid leukemia with a normal karyotype. Genes Chromosomes Cancer 2005; 44: 334\u2013337.","journal-title":"Genes Chromosomes Cancer"},{"key":"BF2404653_CR37","unstructured":"Mitelman F JBaMFE . Mitelman Database of Chromosome Aberrations in Cancer. (2005), Accession Date: 2006. http:\/\/cgap.nci.nih.gov\/Chromosomes\/Mitelman."},{"key":"BF2404653_CR38","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/sj.leu.2404055","volume":"20","author":"RN Sanderson","year":"2006","unstructured":"Sanderson RN, Johnson PR, Moorman AV, Roman E, Willett E, Taylor PR et al. Population-based demographic study of karyotypes in 1709 patients with adult acute myeloid leukemia. Leukemia 2006; 20: 444\u2013450.","journal-title":"Leukemia"},{"key":"BF2404653_CR39","doi-asserted-by":"publisher","first-page":"7012","DOI":"10.1158\/1078-0432.CCR-05-0177","volume":"11","author":"E Blaveri","year":"2005","unstructured":"Blaveri E, Brewer JL, Roydasgupta R, Fridlyand J, DeVries S, Koppie T et al. Bladder cancer stage and outcome by array-based comparative genomic hybridization. Clin Cancer Res 2005; 11: 7012\u20137022.","journal-title":"Clin Cancer Res"},{"key":"BF2404653_CR40","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1471-2407-6-96","volume":"6","author":"J Fridlyand","year":"2006","unstructured":"Fridlyand J, Snijders AM, Ylstra B, Li H, Olshen A, Segraves R et al. Breast tumor copy number aberration phenotypes and genomic instability. BMC Cancer 2006; 6: 96.","journal-title":"BMC Cancer"},{"key":"BF2404653_CR41","doi-asserted-by":"publisher","first-page":"4871","DOI":"10.1182\/blood-2005-08-3272","volume":"107","author":"M Monzo","year":"2006","unstructured":"Monzo M, Brunet S, Urbano-Ispizua A, Navarro A, Perea G, Esteve J et al. Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia. Blood 2006; 107: 4871\u20134879.","journal-title":"Blood"},{"key":"BF2404653_CR42","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cancergencyto.2003.10.005","volume":"152","author":"V Beyer","year":"2004","unstructured":"Beyer V, Castagne C, Muhlematter D, Parlier V, Gmur J, Hess U et al. Systematic screening at diagnosis of -5\/del(5)(q31), -7, or chromosome 8 aneuploidy by interphase fluorescence in situ hybridization in 110 acute myelocytic leukemia and high-risk myelodysplastic syndrome patients: concordances and discrepancies with conventional cytogenetics. Cancer Genet Cytogenet 2004; 152: 29\u201341.","journal-title":"Cancer Genet Cytogenet"},{"key":"BF2404653_CR43","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.molcel.2005.10.003","volume":"20","author":"D Chowdhury","year":"2005","unstructured":"Chowdhury D, Keogh MC, Ishii H, Peterson CL, Buratowski S, Lieberman J . gamma-H2AX dephosphorylation by protein phosphatase 2A facilitates DNA double-strand break repair. Mol Cell 2005; 20: 801\u2013809.","journal-title":"Mol Cell"},{"key":"BF2404653_CR44","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/S0140-6736(03)13166-2","volume":"361","author":"RM Reynolds","year":"2003","unstructured":"Reynolds RM, Browning GG, Nawroz I, Campbell IW . Von Recklinghausen's neurofibromatosis: neurofibromatosis type 1. Lancet 2003; 361: 1552\u20131554.","journal-title":"Lancet"},{"key":"BF2404653_CR45","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1182\/blood-2005-11-011486","volume":"108","author":"K Stephens","year":"2006","unstructured":"Stephens K, Weaver M, Leppig KA, Maruyama K, Emanuel PD, Le Beau MM et al. Interstitial uniparental isodisomy at clustered breakpoint intervals is a frequent mechanism of NF1 inactivation in myeloid malignancies. Blood 2006; 108: 1684\u20131689.","journal-title":"Blood"},{"key":"BF2404653_CR46","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/cncr.11037","volume":"97","author":"D Lu","year":"2003","unstructured":"Lu D, Nounou R, Beran M, Estey E, Manshouri T, Kantarjian H et al. The prognostic significance of bone marrow levels of neurofibromatosis-1 protein and ras oncogene mutations in patients with acute myeloid leukemia and myelodysplastic syndrome. Cancer 2003; 97: 441\u2013449.","journal-title":"Cancer"},{"key":"BF2404653_CR47","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ccr.2005.08.011","volume":"8","author":"RC Chao","year":"2005","unstructured":"Chao RC, Pyzel U, Fridlyand J, Kuo YM, Teel L, Haaga J et al. Therapy-induced malignant neoplasms in Nf1 mutant mice. Cancer Cell 2005; 8: 337\u2013348.","journal-title":"Cancer Cell"},{"key":"BF2404653_CR48","doi-asserted-by":"publisher","first-page":"5869","DOI":"10.1128\/MCB.25.14.5869-5879.2005","volume":"25","author":"G Yang","year":"2005","unstructured":"Yang G, Khalaf W, van de Locht L, Jansen JH, Gao M, Thompson MA et al. Transcriptional repression of the Neurofibromatosis-1 tumor suppressor by the t(8;21) fusion protein. Mol Cell Biol 2005; 25: 5869\u20135879.","journal-title":"Mol Cell Biol"},{"key":"BF2404653_CR49","first-page":"281","volume":"89","author":"B Crescenzi","year":"2004","unstructured":"Crescenzi B, La Starza R, Romoli S, Beacci D, Matteucci C, Barba G et al. Submicroscopic deletions in 5q- associated malignancies. Haematologica 2004; 89: 281\u2013285.","journal-title":"Haematologica"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2404653.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404653","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2404653.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T08:40:10Z","timestamp":1707727210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2404653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,22]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["BF2404653"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2404653","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,22]]},"assertion":[{"value":"17 November 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}